[开放获取]   慢性光化性皮炎诊疗专家共识（2023版）

doi:10.35541/cjd.20230433

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (12): 1096-1106.doi: 10.35541/cjd.20230433

[开放获取] 慢性光化性皮炎诊疗专家共识（2023版）

中国研究型医院学会皮肤科学专业委员会中国医师协会皮肤科医师分会

中国研究型医院学会皮肤科学专业委员会中国医师协会皮肤科医师分会

收稿日期:2023-07-28 修回日期:2023-10-08 发布日期:2023-12-05
通讯作者: 陈崑；鲁严；顾恒 E-mail:kunchen181@aliyun.com

Expert consensus on the diagnosis and treatment of chronic actinic dermatitis （2023）

Dermatology Professional Committee of Chinese Research Hospital Society; China Dermatologist Association

Dermatology Professional Committee of Chinese Research Hospital Society; China Dermatologist Association

Received:2023-07-28 Revised:2023-10-08 Published:2023-12-05
Contact: Chen Kun; Lu Yan; Gu Heng E-mail:kunchen181@aliyun.com

摘要/Abstract

摘要： 【摘要】慢性光化性皮炎是一种好发于中老年男性的光敏感性皮肤病，临床表现为曝光部位湿疹样改变，诊断主要依靠临床表现和光生物学试验，治疗的关键为避光和去除光敏物，其他治疗包括外用药物、物理治疗及系统药物等。中国研究型医院学会皮肤科学专业委员会、中国医师协会皮肤科医师分会组织光皮肤病学领域专家，依据近年来国内外慢性光化性皮炎的最新研究进展，共同讨论慢性光化性皮炎病因及发病机制、临床表现、诊断、鉴别诊断、治疗和预后等临床实践中重点关注的内容，制订慢性光化性皮炎诊疗专家共识（2023版），以期为临床诊疗提供科学、规范的参考依据。

关键词: 皮炎, 光变态反应, 慢性光化性皮炎, 诊断, 治疗, 专家共识

Abstract: 【Abstract】 Chronic actinic dermatitis is a photosensitive dermatosis commonly occurring in middle-aged and elderly males, clinically characterized by eczematous lesions on the sun-exposed skin. The diagnosis mainly relies on clinical manifestations and photobiological tests. The key to treatment is avoidance of sunlight exposure and removal of photosensitizers, and other treatments include topical drugs, physical therapy, systemic drugs, etc. Based on recent research advances in chronic actinic dermatitis in China and other countries, the Dermatology Professional Committee of Chinese Research Hospital Society and the China Dermatologist Association organized experts in the field of photodermatology to discuss the causes, pathogenesis, clinical manifestations, diagnosis, differential diagnosis, treatment and prognosis of chronic actinic dermatitis in clinical practice, and to develop an expert consensus on the diagnosis and treatment of chronic actinic dermatitis （2023）, which provided a scientific and authoritative reference for the diagnosis and management of chronic actinic dermatitis.

Key words: Dermatitis, photoallergic, Chronic actinic dermatitis, Diagnosis, Therapy, Expert consensus

中国研究型医院学会皮肤科学专业委员会中国医师协会皮肤科医师分会. [开放获取] 慢性光化性皮炎诊疗专家共识（2023版）[J]. 中华皮肤科杂志, 2023,56(12):1096-1106. doi:10.35541/cjd.20230433

Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association . Expert consensus on the diagnosis and treatment of chronic actinic dermatitis （2023）[J]. Chinese Journal of Dermatology, 2023, 56(12): 1096-1106.doi:10.35541/cjd.20230433

参考文献 55

［1］	Norris PG, Hawk JL. Chronic actinic dermatitis. A unifying concept［J］. Arch Dermatol, 1990,126（3）:376⁃378.
［2］	Lim HW, Buchness MR, Ashinoff R, et al. Chronic actinic dermatitis. Study of the spectrum of chronic photosensitivity in 12 patients［J］. Arch Dermatol, 1990,126（3）:317⁃323. doi: 10.1001/archderm.126.3.317.
［3］	Dawe RS, Ferguson J. Diagnosis and treatment of chronic actinic dermatitis［J］. DermatolTher, 2003,16（1）:45⁃51. doi: 10.1046/j.1529⁃8019.2003.01607.x.
［4］	Yap LM, Foley P, Crouch R, et al. Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology clinic［J］. Australas J Dermatol, 2003,44（4）:256⁃262. doi: 10.1046/j.1440⁃0960.2003.00004.x.
［5］	陈荃, 张美蓉, 梁慕兰, 等. 慢性光化性皮炎95例临床、光试验和光斑贴试验结果分析［J］. 皮肤性病诊疗学杂志, 2017,24（1）:27⁃31. doi: 10.3969/j.issn.1674⁃8468.2017.01.007.
［6］	李俞晓, 农祥, 何黎, 等. 慢性光化性皮炎及多形性日光疹102例光斑贴试验分析［J］. 临床皮肤科杂志, 2014,43（10）:598⁃600.
［7］	Paek SY, Lim HW. Chronic actinic dermatitis［J］. Dermatol Clin, 2014,32（3）:355⁃361. doi: 10.1016/j.det.2014.03.007.
［8］	Hawk JL. Chronic actinic dermatitis［J］. Photodermatol Photoimmunol Photomed, 2004,20（6）:312⁃314. doi: 10.1111/j.1600⁃0781.2004.00129.x.
［9］	Lee GR. The balance of Th17 versus Treg cells in autoimmunity［J］. Int J Mol Sci, 2018,19（3）:730. doi: 10.3390/ijms19030730.
［10］	Fasching P, Stradner M, Graninger W, et al. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders［J］. Molecules, 2017,22（1）:134. doi: 10.3390/molecules22010134.
［11］	Tan KW, Haylett AK, Ling TC, et al. Comparison of demographic and photobiological features of chronic actinic dermatitis in patients with lighter vs darker skin types［J］. JAMA Dermatol, 2017,153（5）:427⁃435. doi: 10.1001/jamadermatol.2016.5861.
［12］	王丽英, 陈昆, 顾恒, 等. 慢性光线性皮炎紫外线作用光谱的研究［J］. 中华皮肤科杂志, 2005,38（7）:410⁃412.
［13］	王丽英, 陈昆, 朱登平, 等. 慢性光化性皮炎86例临床分析［J］. 中华皮肤科杂志, 2002,35（6）:435⁃438.
［14］	陈教全, 梁碧华, 彭丽倩, 等. 330例慢性光化性皮炎患者紫外线最小红斑量测定［J］. 皮肤性病诊疗学杂志, 2021,28（2）:105⁃109, 113. doi: 10.3969/j.issn.1674⁃8468.2021.02.005.
［15］	Gu Q, Zhang Z, Yang J, et al. Chronic actinic dermatitis: a 5⁃year clinical analysis of 488 patients in China［J］. Photodermatol Photoimmunol Photomed, 2023,39（3）:263⁃268. doi: 10.1111/phpp.12835.
［16］	王广进, 张福仁, 张虹, 等. 慢性光化性皮炎40例临床分析［J］. 中华皮肤科杂志, 2009,42（11）:786⁃787. doi: 10.3760/cma.j.issn.0412⁃4030.2009.11.025.
［17］	Tan AW, Lim KS, Theng C, et al. Chronic actinic dermatitis in Asian skin: a Singaporean experience［J］. Photodermatol Photoimmunol Photomed, 2011,27（4）:172⁃175. doi: 10.1111/j.1600⁃0781.2011.00589.x.
［18］	李凌佳, 刘彤云, 何黎, 等. 慢性光化性皮炎173例临床与病理分析［J］. 中国皮肤性病学杂志, 2018,32（10）:1147⁃1152. doi: 10.13735/j.cjdv.1001⁃7089.201710017.
［19］	王丹旭, 闵仲生. 慢性光化性皮炎30例临床分析［J］. 中国麻风皮肤病杂志, 2017,33（12）:744⁃745.
［20］	赵辨. 中国临床皮肤病学: 上册［M］. 2版. 南京: 江苏凤凰科学技术出版社, 2017:734.
［21］	Forsyth EL, Millard TP. Diagnosis and pharmacological treatment of chronic actinic dermatitis in the elderly: an update［J］. Drugs Aging, 2010,27（6）:451⁃456. doi: 10.2165/11315930⁃000000000⁃00000.
［22］	Meola T, Sanchez M, Lim HW, et al. Chronic actinic dermatitis associated with human immunodeficiency virus infection［J］. Br J Dermatol, 1997,137（3）:431⁃436.
［23］	Vin⁃Christian K, Epstein JH, Maurer TA, et al. Photosensitivity in HIV⁃infected individuals［J］. J Dermatol, 2000,27（6）:361⁃369. doi: 10.1111/j.1346⁃8138.2000.tb02185.x.
［24］	Wang CX, Belsito DV. Chronic actinic dermatitis revisited［J］. Dermatitis, 2020,31（1）:68⁃74. doi: 10.1097/der.000000000000 0531.
［25］	中国医师协会皮肤科医师分会过敏与临床免疫亚专业委员, 中华医学会皮肤性病学分会皮肤免疫学组. 光斑贴试验临床应用专家共识［J］. 中华皮肤科杂志, 2015,48（7）:447⁃450. doi: 10.3760/cma.j.issn.0412⁃4030.2015.07.001.
［26］	中国医师协会皮肤科医师分会皮肤美容事业发展工作委员会. 皮肤防晒专家共识（2017）［J］. 中华皮肤科杂志, 2017,50（5）:316⁃320. doi: 10.3760/cma.j.issn.0412⁃4030.2017.05.002.
［27］	Eadie E, Ferguson J, Moseley H. A preliminary investigation into the effect of exposure of photosensitive individuals to light from compact fluorescent lamps［J］. Br J Dermatol, 2009,160（3）:659⁃664. doi: 10.1111/j.1365⁃2133.2008.08998.x.
［28］	顾恒, 常宝珠, 陈崑. 光皮肤病学［M］. 北京: 人民军医出版社, 2009:187⁃188.
［29］	功效性护肤品在慢性光化性皮炎中的应用指南专家组. 功效性护肤品在慢性光化性皮炎中的应用指南［J］. 中国皮肤性病学杂志, 2020,34（1）:1⁃4. doi: 10.13735/j.cjdv.1001⁃7089. 201912048.
［30］	Moseley H, Cameron H, Macleod T, et al. New sunscreens confer improved protection for photosensitive patients in the blue light region［J］. Br J Dermatol, 2001,145（5）:789⁃794. doi: 10.1046/j.1365⁃2133.2001.04429.x.
［31］	Gröne D, Kunz M, Zimmermann R, et al. Successful treatment of nodular actinic reticuloid with tacrolimus ointment［J］. Dermatology, 2006,212（4）:377⁃380. doi: 10.1159/000092291.
［32］	Uetsu N, Okamoto H, Fujii K, et al. Treatment of chronic actinic dermatitis with tacrolimus ointment［J］. J Am AcadDermatol, 2002,47（6）:881⁃884. doi: 10.1067/mjd.2002.124703.
［33］	Larangeira de Almeida H Jr. Successful treatment of chronic actinic dermatitis with topical pimecrolimus［J］. Int J Dermatol, 2005,44（4）:343⁃344. doi: 10.1111/j.1365⁃4632.2005.02352.x.
［34］	Alquier⁃Bouffard A, Da Costa CM, Roger H, et al. Chronic actinic dermatitis: treatment with topical tacrolimus （two cases）［J］. Ann DermatolVenereol, 2007,134（6⁃7）:555⁃558. doi: 10. 1016/s0151⁃9638（07）89268⁃4.
［35］	王才惠, 段西凌. 羟氯喹在治疗皮肤病中的应用［J］. 临床皮肤科杂志, 2013,42（4）:259⁃261. doi: 10.3969/j.issn.1000⁃4963.2013.04.033.
［36］	靳培英. 皮肤病药物治疗学［M］. 2版. 北京: 人民卫生出版社, 2009:132.
［37］	阎春林, 廖康煌, 马莉. 羟基氯喹治疗光线性皮肤病的回顾性分析［J］. 临床皮肤科杂志, 2001,30（6）:369⁃370. doi: 10.3969/j.issn.1000⁃4963.2001.06.015.
［38］	Yusuf IH, Latheef F, Ardern⁃Jones M, et al. New recommen⁃dations for retinal monitoring in hydroxychloroquine users: baseline testing is no longer supported［J］. Br J Dermatol, 2021,185（2）:435⁃438. doi: 10.1111/bjd.20073.
［39］	Goldsmith LA, Katz SI, Gilchrest BA, et al. Fitzpatrick′s dermatology in general medicine［M］. 8th edition, New York: McGraw⁃Hill Companies, 2012:1060.
［40］	Murphy GM, Maurice PD, Norris PG, et al. Azathioprine treatment in chronic actinic dermatitis: a double⁃blind controlled trial with monitoring of exposure to ultraviolet radiation［J］. Br J Dermatol, 1989,121（5）:639⁃646. doi: 10.1111/j.1365⁃2133.1989. tb08197.x.
［41］	Paracha MM, Zahoor H, Khan AQ, et al. Efficacy of methotrexate versus azathioprine in the treatment of chronic actinic dermatitis: a randomized control trial［J］. J Ayub Med Coll Abbottabad, 2022,34（Suppl 1）（3）:S644⁃S648. doi: 10.55519/JAMC⁃03⁃S1⁃9643.
［42］	Chen JC, Lian CH. Chronic actinic dermatitis in an old adult significantly improved by dupilumab［J］. Photodermatol Photoimmunol Photomed, 2022,38（2）:176⁃177. doi: 10.1111/phpp.12731.
［43］	Kaushik A, Narang T, Handa S. Successful use of apremilast as a steroid⁃sparing agent in chronic actinic dermatitis［J］. Dermatol Ther, 2020,33（6）:e13809. doi: 10.1111/dth.13809.
［44］	Patel N, Konda S, Lim HW. Dupilumab for the treatment of chronic actinic dermatitis［J］. Photodermatol Photoimmunol Photomed, 2020,36（5）:398⁃400. doi: 10.1111/phpp.12566.
［45］	Pita da Veiga G, Pérez⁃Feal P, Peña⁃López S, et al. Apremilast⁃induced photosensitivity confirmed by photobiological study［J］. Photodermatol Photoimmunol Photomed, 2021,37（1）:68⁃70. doi: 10.1111/phpp.12589.
［46］	Majid I, Akhtar S. Tofacitinib in resistant chronic actinic dermatitis: a case series［J］. DermatolTher, 2022,35（6）:e15467. doi: 10.1111/dth.15467.
［47］	中华医学会皮肤性病学分会免疫学组. 特应性皮炎的全程管理共识［J］. 中华皮肤科杂志, 2023,56（1）:5⁃15. doi: 10.35541/cjd.20220618.
［48］	Hindson C, Spiro J, Downey A. PUVA therapy of chronic actinic dermatitis［J］. Br J Dermatol, 1985,113（2）:157⁃160. doi: https://doi.org/10.1111/j.1365⁃2133.1985.tb02058.x.
［49］	Ma L, Zhang Q, Hu Y, et al. Evaluation of narrow band ultraviolet B phototherapy in the treatment of chronic actinic dermatitis in Chinese patients［J］. DermatolTher, 2017,30（6）. doi: 10.1111/dth.12528.
［50］	Wang T, Gong Y, Rong W, et al. Ultraviolet A rush hardening for chronic actinic dermatitis: pilot treatment outcomes［J］. J Dermatol, 2021,48（3）:385⁃388. doi: 10.1111/1346⁃8138.15667.
［51］	马莉, 胡跃, 徐昱, 等. 窄谱中波紫外线治疗慢性光线性皮炎的方案及影响因素分析［J］. 中华皮肤科杂志, 2017,50（8）:571⁃574. doi: 10.3760/cma.j.issn.0412⁃4030.2017.08.006.
［52］	Chee SN, Novakovic L, Fassihi H, et al. Chronic actinic dermatitis: successful treatment with psoralen⁃ultraviolet A photochemotherapy［J］. Br J Dermatol, 2018,178（3）:e189⁃e190. doi: 10.1111/bjd.15969.
［53］	Lembo S, Raimondo A. Polymorphic light eruption: what′s new in pathogenesis and management［J］. Front Med （Lausanne）, 2018,5:252. doi: 10.3389/fmed.2018.00252.
［54］	Libon F, Nikkels AF. Polymorphous light eruption: phototherapy⁃based desensitization versus intramuscular steroids⁃who is right, who is wrong?［J］. Dermatology, 2018,234（5⁃6）:192⁃193. doi: 10.1159/000492749.
［55］	Dawe RS, Crombie IK, Ferguson J. The natural history of chronic actinic dermatitis［J］. Arch Dermatol, 2000,136（10）:1215⁃1220. doi: 10.1001/archderm.136.10.1215.

[1]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会中国中西医结合学会皮肤性病专业委员会 . [开放获取] 中国化学剥脱术临床应用专家共识（公众版2024版）[J]. 中华皮肤科杂志, 2024, 0(5): 20230620-e20230620.
[2]	陈星宇姚煦. 中性粒细胞在炎症性皮肤病中的研究进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220865-e20220865.
[3]	戴叶芹宋秀祖. 毛囊及毛囊细胞移植在白癜风治疗中的应用进展[J]. 中华皮肤科杂志, 2024, 0(3): 20230274-e0230274.
[4]	陈竹董丽萍肖风丽. 基于代谢组学探究特应性疾病的研究进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220366-e20220366.
[5]	陈立新王莹高西波秦蓓李钦峰. 儿童经典型和色素减退型扁平疣反射式共聚焦显微镜特征及与组织病理的对应关系初探[J]. 中华皮肤科杂志, 2024, 0(2): 20220419-e20220419.
[6]	中国医师协会皮肤科医师分会中华医学会皮肤性病学分会中国医疗保健国际交流促进会皮肤医学分会疑难重症及罕见病国家重点实验室国家皮肤与免疫疾病临床医学研究中心. 特应性皮炎治疗药物应用管理专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 97-108.
[7]	中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 109-118.
[8]	李吉谢红付. 如何避免玫瑰痤疮的误诊[J]. 中华皮肤科杂志, 2024, 57(2): 119-122.
[9]	那君李若瑜仲少敏杨莉吴艳. 玫瑰痤疮真实世界诊疗现状调查分析[J]. 中华皮肤科杂志, 2024, 57(2): 127-133.
[10]	王诗琪王爱平李航李若瑜. 趾甲银屑病与指甲银屑病的皮肤镜特征比较[J]. 中华皮肤科杂志, 2024, 57(2): 161-165.
[11]	赵迎高翠娥隋昕宋志强. 基于高加索人单细胞转录组的炎症性树突状表皮细胞的免疫代谢研究[J]. 中华皮肤科杂志, 2024, 0(2): 20230550-e20230550.
[12]	王雨婷姚曼雪周乃慧. 联合微针治疗雄激素性秃发的研究进展[J]. 中华皮肤科杂志, 2024, 57(1): 82-84.
[13]	高艳王鹏康晓静. 卡波西肉瘤治疗研究新进展[J]. 中华皮肤科杂志, 2024, 57(1): 85-89.
[14]	中国中西医结合学会皮肤性病专业委员会皮肤肿瘤学组中国抗癌协会黑色素瘤专业委员会. [开放获取] 人干扰素α1b治疗黑色素瘤专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(1): 1-7.
[15]	古丽孜巴·图尔荪屈园园. Janus激酶-信号转导及转录激活因子信号通路抑制剂在白癜风治疗中的新进展[J]. 中华皮肤科杂志, 2024, 57(1): 71-75.

[开放获取] 慢性光化性皮炎诊疗专家共识（2023版）

Expert consensus on the diagnosis and treatment of chronic actinic dermatitis （2023）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 55

相关文章 15

Metrics

本文评价

推荐阅读 10